US FDA approves GE HealthCare’s diagnostic drug for the treatment of heart disease

The US Food and Drug Administration has approved a GE HealthCare diagnostic drug for use in detecting coronary heart disease, the company said on Friday.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO